Israel Active

Israeli biotech Kamada has started producing anti-viper venom serum as a national priority project, financed with NIS 20 million of government money.

Israel may have invented the most sophisticated scanning techniques, but Kaplan Rehovot researchers have proved that basic clinical skills give the most accurate results.

Researchers at Tel Aviv University have developed a computerised genome-scale model of cancer cell metabolism which can help predict which treatments patients will have an effective response to.

Israel’s Andromeda Biotech is conducting Phase III tests of its synthetic peptide in America, Europe and Israel. DiaPep277 can preserve the few remaining insulin cells of sufferers.

Israel’s WideMed Ltd has just received the CE mark for its mobile sleep apnea system Morpheus Ox for home use.

Israel Technion’s Prof Lior Gepstein produced a unique model for research and treatment of heart disease. He has also transformed adult skin stem cells into heart cells.

Especially when you are a hen. The eggs we eat can damage our health if the diet of the hen that laid them was bad. Research by Dr. Niva Shapira of Tel Aviv University has proved this.

Trials at Hadassah hospital in Jerusalem have proved that Deep Transcranial Magnetic Stimulation (TMS) therapy is safe and effective in treating Post Traumatic Stress Disorder (PTSD).

Israel’s Apos’ walkright attaches to shoes to strengthen the knee muscles and alleviate pain. So far they have treated 20,000 patients – half of them in Israel. New funding will help them expand.

Israel is giving 2.2 million shekels for trials by Israeli bio-tech Biocancell into the effectiveness of its BC-819 drug in treating pancreatic cancer. BC-819 may also treat other cancers.